Trevena, Inc. (TRVN) Financials
TRVN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 45.1 million | 41.6 million |
2023-06-30 | 38.9 million | 29.1 million |
2023-03-31 | 38.3 million | 28.1 million |
2022-12-31 | 48.7 million | 33.1 million |
TRVN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -8.9 million | 689000 |
2023-06-30 | -7.3 million | 702000 |
2023-03-31 | -10.9 million | 806000 |
2022-12-31 | -10.6 million | 749000 |
TRVN Net Income
No data available :(
TRVN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 35.0 million | - | 5.7 million |
2023-06-30 | 28.1 million | - | 5.9 million |
2023-03-31 | 27.4 million | - | 6.1 million |
2022-12-31 | 38.3 million | - | 6.3 million |
TRVN Shares Outstanding
TRVN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 4.3 million | 4.6 million | - |
2023-06-30 | 20000 | 4.0 million | 5.1 million | - |
2023-03-31 | - | 3.9 million | 6.1 million | - |
2022-12-31 | 27972 | 3.4 million | 21.3 million | 15.6 million |
TRVN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 180000 | 175000 |
2023-06-30 | 3.0 million | 88000 |
2023-03-31 | 6000 | 127000 |
2022-12-31 | - | 228000 |
TRVN
Price: $0.41
52 week price:
Earnings Per Share: -3.16 USD
P/E Ratio: -0.10
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 42100
Ebitda: -15.1 millionMarket Capitalization: 7.0 million